75
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Murine hepatitis virus--A model for virus-induced CNS demyelination

Pages 76-85 | Published online: 10 Jul 2009

References

  • Barthold SW, Smith AL (1992). Viremic dissemination of mouse hepatitis virus-JHM following intranasal inocu-lation of mice. Arch Virol 122: 35–44.
  • Bergmann CC, Altman JD, Hinton D, Stohlman SA (1999). Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol 163: 3379–3387.
  • Bergmann CC, Ramakrishna C, Kornacki M, Stohlman SA (2001). Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol 167: 1575–1583.
  • Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Goverman J (2000). In situ tolerance within the central nervous system as a mechanism for preventing autoim-munity. J Exp Med 192: 871–880.
  • Braun JS, Kaissling B, Le Hir M, Zenker W (1993). Cel-lular components of the immune barrier in the spinal meninges and dorsal root ganglia of the normal rat: Immunohistochemical (MHC class II) and electron-microscopic observations. Cell Tissue Res 273: 209–217.
  • Brehm U, Piddlesden SJ, Gardinier MV, Linington C (1999). Epitope specificity of demyelinating monoclonal au-toantibodies directed against the human myelin oligo-dendrocyte glycoprotein (MOG). I Neuroimmunol 97: 9–15.
  • Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984). Murine hepatitis virus-4 (strain JHM)-induced neuro-logic disease is modulated in vivo by monoclonal an-tibody. Virology 132: 261–270.
  • Coutelier JP, Godfraind C, Dveksler GS, Wysocka M, Cardellichio CB, Noel H, Holmes KV (1994). B lympho-cyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as recep-tors for murine coronavirus. Eur J. Immunol 24: 1383–1390.
  • Coutelier JP, van der Logt JT, Heessen FW, Warnier G, Van Snick J (1987). IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165: 64–69.
  • Cserr HF, DePasquale M, Harling-Berg CJ, Park JT, Knopf PM (1992). Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability. J Neuroimmunol 41: 195–202.
  • Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E (2000). De-myelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J. Virol 74: 9206–9213.
  • Even C, Rowland RR, Plagemann PG (1995). Mouse hepati-tis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations. Virus Res 39: 355–364.
  • Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA (1989). Monoclonal antibodies to the matrix (El) gly-coprotein of mouse hepatitis virus protect mice from en-cephalitis. Virology 168: 162–167.
  • Genain CP, Cannella B, Hauser S, Raine CS (1999). Identifi-cation of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5: 170–175.
  • Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M (1989). In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. I Cell Biol 109: 2405–2416.
  • Godfraind C, Holmes KV, Coutelier JP (1995). Thymus invo-lution induced by mouse hepatitis virus A59 in BALB/c mice. I Virol 69: 6541–6547.
  • Gombold JL, Sutherland RM, Lavi E, Paterson Y, Weiss SR (1995). Mouse hepatitis virus A59-induced demyelina-tion can occur in the absence of CD8+ T cells. Microb Pathog 18: 211–221.
  • Gordon LB, Nolan SC, Ksander BR, Knopf PM, Harling-Berg CJ (1998). Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells: Role of the brain microenvironment in CNS immune regulation. J Neuroimmunol 88: 77–84.
  • Herndon RM, Griffin DE, McCormick U, Weiner LP (1975). Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol 32: 32–35.
  • Herndon RM, Price DL, Weiner LP (1977). Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693–694.
  • Hickey WF, Kimura H (1988). Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290–292.
  • Holmes KV, Lai MCC (1996). Coronaviridae: The viruses and their replication. In Fields virology, V1. Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven: Philadelphia, pp 1075–1093.
  • Hooper DC, Kean RB, Scott GS, Spitsin SV, Mikheeva T, Morimoto K, Bette M, Rohrenbeck AM, Dietzschold B, Weihe E (2001). The central nervous system in-flammatory response to neurotropic virus infection is peroxynitrite dependent. I Immunol 167: 3470–3477.
  • Horwitz MS, Evans CF, Klier FG, Oldstone MB (1999). Detailed in vivo analysis of interferon-gamma induced major hist oc omp atibility complex expression in the cen-tral nervous system: Astrocytes fail to express major his-tocompatibility complex class I and II molecules. Lab Invest 79: 235–242.
  • Houtm an JJ, Fleming JO (1996). Dissociation of demyeli-nation and viral clearance in congenitally immuno-deficient mice infected with murine coronavirus JHM. J NeuroVirol 2: 101–110.
  • Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD (1995). Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental au-toimmune encephalomyelitis in Lewis rats. Clin Exp Immunol 100: 344–351.
  • Irani DN, Lin KI, Griffin DE (1997). Regulation of brain-derived T cells during acute central nervous system inflammation. J Immunol 158: 2318–2326.
  • Joseph J, Kim R, Siebert K, Lublin FD, Offenbach C, Knobler RL (1995). Organ specific endothelial cell heterogeneity influences differential replication and cytopathogenic - ity of MHV-3 and MHV-4. Implications in viral tropism. Adv Exp Med Biol 380: 43–50.
  • Kajino K, Kajino Y, Greene MI (1998). Fas- and perforin-independent mechanisms of cytotoxic T lymphocyte. Immunol Res 17: 89–93.
  • Knobler RL, Lampert PW, Oldstone MB (1982). Virus per-sistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298: 279–280.
  • Knobler RL, Oldstone, MB (1987). Infection and involution of mouse thymus by MHV-4. Adv Exp Med Biol 218: 451–453.
  • Koolen MJ, Love S, Wouda W, Calafat J, Horzinek MC, van der Zeijst BA (1987). Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A59 is associated with restriction of viral replication in the brain. I Gen Virol 68: 703–714.
  • Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B (1993). In vivo expres-sion of inducible nitric oxide synthase in experimen-tally induced neurologic diseases. Proc Nail Acad Sci USA 90: 3024–3027.
  • Korner H, Schliephake A, Winter J, Zimprich F, Lassmann H, Sedgwick J, Siddell S, Wege H (1991). Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induce d encephalomyelitis in the absence of CD8+ T cells. J Immunol 147: 2317–2323.
  • Kristensson K, Norrby E (1986). Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol 40: 159–184.
  • Kyuwa S, Machii K, Shibata S (1996). Role of CD4+ and CD8+ T cells in mouse hepatitis virus infection in mice. Exp Anim 45: 81–83.
  • Lampert PW (1978). Autoimmune and virus induced de-myelinating diseases. A review. Am I Pathol 91: 176–208.
  • Lampert PW, Sims JK, Kniazeff AJ (1973). Mechanism of de-myelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 24: 76–85.
  • Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ (1998). Dynamic regulation of a- and /3-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970–978.
  • Lane TE, Buchmeier MJ (1999). Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: Implications for N052/NO reg-ulation of chemokine expression and inflammation. J NeuroVirol 5: 48–54.
  • Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ (2000). A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. I Virol 74: 1415–1424.
  • Lane TE, Paoletti AD, Buchmeier MJ (1997). Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. I Virol 71: 2202–2210.
  • Lardans V, Godfraind C, van der Logt JT, Heessen WA, Gonzalez MD, Coutelier JP (1996). Polyclonal B lympho-cyte activation induced by mouse hepatitis virus A59 infection. I Gen Virol 77: 1005–1009.
  • Lavi E, Das Sarma J, Weiss SR (1999). Cellular reser-voirs for coronavirus infection of the brain in beta2 - microglobulin knockout mice. Path obiology 67: 75–83.
  • Lavi E, Gilden DH, Highkin MK, Weiss SR (1984a). Detec-tion of MHV-A59 RNA by in situ hybridization. Adv Exp Med Biol 173: 247–257.
  • Lavi E, Gilden DH, Highkin MK, Weiss SR (1986). The organ tropism of mouse hepatitis virus A59 in mice is depen-dent on dose and route of inoculation. Lab Anim Sci 36: 130–135.
  • Lavi E, Gilden DH, Wroblewska Z, Rorke RB, Weiss SR (1984b). Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34: 597–603.
  • Lavi E, Murray EM, Makin° S, Stohlman SA, Lai MM, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3' portions of the genome as determined by ribonucleic acid-ribonucleic acid re-combination. Lab Invest 62: 570–578.
  • Lavi E, Suzumur a A, Hirayama M, Highkin MK, Dambach DM, Silberberg DH, Weiss SR (1987). Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, produc-tive infection in primary glial cell cultures. Microb Pathog 3: 79–86.
  • Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR (1998). Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. I Virol 72: 9628–9636.
  • Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA (1999). Antibody prevents virus reactivation within the central nervous system. Jimmunol 162: 7358–7368.
  • Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC (1998). The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virol-ogy 245: 270–280.
  • Lin MT, Stohlman SA, Hinton DR (1997). Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. I Virol 71: 383–391.
  • Lin RF, Lin T-S, Tilton RG, Cross (1993). Nitric oxide local-ized in the spinal cords of mice with experimental aller-gic encephalomyelitis: An electroparamagrietic study. J Exp Med 178: 643–648.
  • Lipton HL, Gonzalez-Scaran o F (1978). Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J. Infect Dis 137: 145–151.
  • Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE (2000). Cutting edge: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165: 2327–2330.
  • Marten NW, Stohlman SA, Atkinson RD, Hinton DR, Fleming JO, Bergmann CC (2000). Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol 164: 4080–4088.
  • Matthews AE, Lavi E, Weiss SR, Paterson Y (2002). Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. JNeuroVirol, in press.
  • Matthews AE, Weiss SR, Shlomchik M, Hannum LG, Gombold JL, Paterson Y (2001). Antibody is required for clearance of infectious murine hepatitis virus A59 from the CNS but not the liver. Jimmunol, in press.
  • Murray RS, Cai GY, Hoel K, Zhang JY, Soike KF, Cabirac GF (1992). Coronavirus infects and causes demyelination in primate central nervous system. Virology 188: 274–284.
  • Navas S, Seo SH, Chua MM, Sarma JD, Lavi E, Hingley ST, Weiss SR (2001). Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. I Virol 75: 2452–2457.
  • Pachuk CJ, Bredenbeek PJ, Zoltick PW, Spaan WJ, Weiss SR (1989). Molecular cloning of the gene encoding the pu-tative polymerase of mouse hepatitis coronavirus, strain A59. Virology 171: 141–148.
  • Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA (1997). Kinetics of cytokine mRNA expression in the cen- tral nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 233: 260–270.
  • Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA (1999). IFN-gamma is required for viral clearance from central nervous system oligo-dendroglia. J Immunol 162: 1641–1647.
  • Parra, Lin MT, Stohlman SA, Bergmann CC, Atkinson R, Hinton DR (2000). Contributions of Fas-Fas ligand in-teractions to the pathogenesis of mouse hepatitis virus in the central nervous system. I Virol 74: 2447–2450.
  • Perlman S, Jacobsen G, Afifi A (1989). Spread of a neu-rotropic murine coronavirus into the CNS via the trigem-inal and olfactory nerves. Virology 170: 556–560.
  • Perlman S, Ries D (1987). The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathog 3: 309–314.
  • Phillips JJ, Chua MM, Lavi E, Weiss SR (1999). Pathogenesis of chimeric MHV-4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. I Virol 73: 7752–7760.
  • Powell HC, Lampert PW (1975). Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab Invest 33: 440–445.
  • Rossi CP, Delcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M (1997). Role of macrophages during Theiler's virus infection. I Virol 71: 3336–3340.
  • Schijns VE, Wierda CM, van Hoeij M, Horzinek MC (1996). Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. I Immunol 157: 815–821.
  • Schwender S, Hein A, Imrich H, Czub S, Dorries R (1999). Modulation of acute coronavirus-induce d en-cephalomyelitis in gamma-irradiated rats by transfer of naïve lymphocyte subsets before infection. J NeuroVirol 5: 249–257.
  • Stevenson PG, Freeman S, Bangham CR, Hawke S (1997). Virus dissemination through the brain parenchyma without immunologic control. I Immunol 159: 1876–1884.
  • Stohlman SA, Bergmann CC, Cua DJ, Lin MT, Ho S, Wei W, Hinton DR (1998a). Apoptosis of JHMV-specific CTL in the CNS in the absence of CD4+ T cells. Adv Exp Med Biol 440: 425–430.
  • Stohlman SA, Bergmann CC, Lin MT, Cua DJ, Hinton DR (1998b). CTL effector function within the central ner-vous system requires CD4+ T cells. I Immunol 160: 2896–2904.
  • Stohlman SA, Bergmann CC, van der Veen RC, Hinton DR (1995a). Mouse hepatitis virus-specific cytotoxic T lym-phocytes protect from lethal infection without eliminat-ing virus from the central nervous system. I Virol 69: 684–694.
  • Stohlman SA, Hinton DR, Cua D, Dimacali E, Sensintaffar J, Hofman FM, Tahara SM, Yao Q (1995b). Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. I Virol 69: 5898–5903.
  • Stohlman SA, Matsushima GK, Casteel N, Weiner LP (1986). In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. I Immunol 136: 3052–3056.
  • Stohlman SA, Weiner LP (1981). Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31: 38–44.
  • Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S(1995). Activation of astrocytes in the spinal cord of mice chron-ically infected with a neurotropic coronavirus. Virology 213: 482–493.
  • Sun N, Perlman S (1995). Spread of a neurotropic corona-virus to spinal cord white matter via neurons and astro-cytes. I Virol 69: 633–641.
  • Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y (1997). CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J NeuroVirol 3: 225–228.
  • Suzumur a A, Lavi E, Weiss SR, Silberberg DH (1986). Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232: 991–993.
  • Takahashi K, Goto N, Matsubar a Y, Fujiwara K (1987). Post inflammatory remyelination in the spinal cord of mice infected with mouse hepatitis virus, JHM strain. Jpn J Exp Med 57: 145–151.
  • Wang Fl, Hinton DR, Gilmore W, Trous dale MD, Fleming JO (1992). Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a character-istic distribution of demyelination. Lab Invest 66: 744–754.
  • Wang Q, Haluskey JA, Lavi E (1998). Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures. Adv Exper Med Biol 440: 451–454.
  • Weiner LP (1973). Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol 28: 298–303.
  • Wijburg OL, HeemskerkMH, Boog CJ, Van Rooijen N (1997). Role of spleen macrophages in innate and acquired im-mune responses against mouse hepatitis virus strain A59. Immunology 92: 252–258.
  • Wijburg OL, Heemskerk MH, Sanders A, Boog CJ, Van Rooijen N (1996). Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 87: 34–41.
  • Williams RK, Jiang GS, Holmes KV (1991). Receptor for mouse hepatitis virus is a member of the carcinoembry - onic antigen family of glycoproteins. Proc Natl Acad Sci USA 88: 5533–5536.
  • Williamson JSP, Stohlman SA (1990). Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. I Virol 64: 4589–4592.
  • Williamson JSP, Sykes KC, Stohlman SA (1991). Charac-terization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. I Neu-roimmunol 32: 199–207.
  • Wu, GF, Dandekar AA, Pewe L, Perlman S (2000). CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 165: 2278–2286.
  • Wu GF, Perlman S (1999). Macrophage infiltration, but not apoptosis, is correlated with immune-mediated de-myelination following murine infection with a neu-rotropic coronavirus. I Virol 73: 8771–8780.
  • Xue S, Sun N, Van Rooijen N, Perlman S (1999). Depletion of blood-borne macrophages does not reduce demyeli-nation in mice infected with a neurotropic coronavirus. Virol 73: 6327–6334.
  • Yokomori K, Baker SC, Stohlman SA, Lai MM (1992). Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. Virol 66: 2865–2874.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.